People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.
IGNITE update – Eight hospitals have been enrolled in the program
IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.